OBERLAND CAPITAL
Oberland Capital provides innovative financing solutions to companies and royalty holders in the healthcare industry. We specialize in flexible investment structures customized to meet the specific capital requirements and strategic objectives of transaction partners globally. Our broad suite of financing solutions includes monetization of royalty streams, acquisition of future product revenues, creation of project-based financing structures, and investment in debt and equity securities. With a combination of deep industry knowledge and extensive structured finance experience, the Oberland Capital team has a history of creating value for our transaction partners.
OBERLAND CAPITAL
Social Links:
Industry:
Asset Management Financial Services Venture Capital
Founded:
2013-01-01
Status:
Active
Contact:
212-257-5850
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics Content Delivery Network Google Universal Analytics Font Awesome Mobile Non Scaleable Content Sitelinks Search Box Google Maps
Similar Organizations
Equinox Capital
Equinox Capital provides its services to investment companies.
FlatWorld Capital
FlatWorld Capital provides financing solutions to middle-market companies.
Tahoma Ventures
Tahoma Ventures provides early stage capital to IT technology startups.
Third Eye Capital
Third Eye Capital provides innovative and customized lending solutions for companies.
TMT Investments
TMT Investments provides investors with liquid exposure to a diversified portfolio of earlier-stage technology startups.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-12-14 | Zealand Pharma | Oberland Capital investment in Post-IPO Debt - Zealand Pharma | 200 M USD |
| 2021-10-04 | Centessa Pharmaceuticals | Oberland Capital investment in Post-IPO Debt - Centessa Pharmaceuticals | 300 M USD |
| 2021-04-26 | Esperion | Oberland Capital investment in Post-IPO Equity - Esperion | 50 M USD |
| 2020-12-09 | Mirum Pharmaceuticals | Oberland Capital investment in Post-IPO Equity - Mirum Pharmaceuticals | 10 M USD |
| 2020-10-27 | Primmune Therapeutics | Oberland Capital investment in Series A - Primmune Therapeutics | 27.4 M USD |
| 2019-04-23 | NorthStar Medical Radioisotopes | Oberland Capital investment in Venture Round - NorthStar Medical Radioisotopes | 75 M USD |
| 2017-10-26 | Impact Biomedicines | Oberland Capital investment in Debt Financing - Impact Biomedicines | 90 M USD |
| 2017-06-29 | Melinta Therapeutics | Oberland Capital investment in Post-IPO Equity - Melinta Therapeutics | 90 M USD |
More informations about "Oberland Capital"
About - Oberland Capital
Founded in 2013, Oberland Capital is a dedicated healthcare investment firm with approximately $3.2 billion in assets under management. We specialize in flexible investment structures for …See details»
Team - Oberland Capital
The Oberland Capital investment team has over 200 years of combined relevant healthcare and investment experience. We possess significant scientific, operational, and financial expertise built throughout long tenures in the …See details»
Oberland Capital - Crunchbase Investor Profile
Oberland Capital provides innovative financing solutions to companies and royalty holders in the healthcare industry. We specialize in flexible investment structures customized to meet the specific capital requirements and strategic objectives …See details»
Oberland Capital - LinkedIn
Oberland Capital is a private investment firm formed in 2013 with assets under management in excess of $3 billion, focused exclusively on investing in the global healthcare industry and ...See details»
ImmunityBio Announces $320 Million Investment by Oberland …
Jan 2, 2024 Oberland Capital is a private investment firm formed in 2013 with assets under management of approximately $3.5 billion, focused exclusively on investing in the global …See details»
Oberland Capital - Investments, Portfolio & Company Exits
Oberland Capital 's most notable exits include ImmunityBio, ... Which industries has this organization had the most exits in? Show . ImmunityBio ImmunityBio is a late-stage …See details»
Oberland Capital - Crunchbase Investor Profile & Investments
Oberland Capital provides innovative financing solutions to companies .See details»
Oberland Capital - Funding, Financials, Valuation & Investors
Oberland Capital has raised a total of $2.4B across 3 funds, their latest being Oberland Capital Healthcare Fund III LP. This fund was announced on Oct 13, 2022 and raised a total of . …See details»
Strategy - Oberland Capital
Oberland Capital’s broad suite of flexible financing solutions includes monetization of royalty streams, acquisition of future product revenues, creation of project-based financing structures, …See details»
Oberland Capital Closes Third Healthcare Royalty and Credit ...
Oct 13, 2022 Oberland Capital is a private investment firm formed in 2013 with assets under management in excess of $3 billion, focused exclusively on investing in the global healthcare …See details»
ImmunityBio inks $210M royalty deal to get cancer drug to market
Jan 2, 2024 ImmunityBio has traded future profits for cash to kick off commercialization of its near-approval cancer drug candidate. Oberland Capital took the other side of the deal, …See details»
Oberland Capital Closes Third Healthcare Royalty and Credit ...
Oberland Capital is a private investment firm formed in 2013 with assets under management in excess of $3 billion, focused exclusively on investing in the global healthcare industry and …See details»
Oberland Capital nabs $1.05B raise for late-stage plays, handing …
May 5, 2020 A month later, and Oberland Capital is joining the party with its $1.05 billion, which it says will focus on biotechs and medtechs in the later stages of development and is the New …See details»
Oberland Capital - Contacts, Employees, Board Members
Oberland Capital has 4 current employee profiles, including Managing Partner & FOUNDER Jean-Pierre Naegeli. Contacts. Edit Contacts Section. Job Department. Protected Content. Chief …See details»
News - Oberland Capital
Oct 13, 2023 Oberland Capital Raises $1.05 Billion Healthcare Royalty Fund to Invest in Companies Advancing Products in Late-Stage Clinical Development April 23, 2019 NorthStar …See details»
Oberland Capital — 11 Investments, 6 Exits, 10 ... - Unicorn Nest
Oberland Capital appeared to be the VC, which was created in 2013. The leading representative office of defined VC is situated in the New York. The venture was found in North America in …See details»
Oberland Capital Raises $1.05 Billion Healthcare Royalty Fund to …
May 5, 2020 Oberland Capital, a private investment firm with over $2.25 billion in capital commitments since inception, is focused exclusively on investing in the global healthcare …See details»
Portfolio - Oberland Capital
Axogen is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen's platform for peripheral nerve repair …See details»